id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-N-0374-0016,FDA,FDA-2009-N-0374,"Ellen Frank, Director Division of Public Affairs - ""Educating the Public On the Phase-Out of Epinephrine CFC Inhalers"" [Public Workshop, September 25, 2009] - Testimony",Other,TS-Testimony,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2013-07-27T23:01:22Z,,0,0,0900006480a62271
FDA-2009-N-0374-0014,FDA,FDA-2009-N-0374,"Nancy Sander, Allergy and Asthma Network, Mothers of Asthmatics (AANMA) ""OTC Bronchodilator MDIS: Patient/Parent Perspectives"" - [Public Workshop, September 25, 2009] - Testimony",Other,TS-Testimony,2009-12-02T05:00:00Z,2009,12,2009-12-02T05:00:00Z,,2013-07-27T23:01:22Z,,0,0,0900006480a6226d
FDA-2009-N-0374-0015,FDA,FDA-2009-N-0374,"Charlotte W. Collins, J.D., Asthma and Allergy Foundation of America (AAFA) - [Public Workshop, September 25, 2009] - Testimony",Other,TS-Testimony,2009-12-02T05:00:00Z,2009,12,2009-12-02T05:00:00Z,,2013-07-27T23:01:22Z,,0,0,0900006480a6226f
FDA-2009-N-0374-0012,FDA,FDA-2009-N-0374,"Educating the Public About Removal of Essential-Use Designation for Epinephrine; Public Workshop, (""Phase Out of CFC-Propelled Epinephrine Inhalation Aerosol""), September 25, 2009 - Transcript",Other,TR-Transcript,2009-11-27T05:00:00Z,2009,11,2009-11-27T05:00:00Z,,2009-11-27T17:24:26Z,,0,0,0900006480a5f2ca
FDA-2009-N-0374-0008,FDA,FDA-2009-N-0374,"Steve Campbell, Esq., ""Epinephrine Use and Communication Plan"" [Public Workshop, September 25, 2009] - Testimony",Other,TS-Testimony,2009-10-20T04:00:00Z,2009,10,2009-10-20T04:00:00Z,,2013-08-11T03:04:29Z,,0,0,0900006480a36820
FDA-2009-N-0374-0007,FDA,FDA-2009-N-0374,"Marcus M. Reidenberg, MD, ""Perspective on Underserved Populations: Is the Need for Prescriptions a Barrier to Care?"" [Public Workshop, September 25, 2009] - Testimony",Other,TS-Testimony,2009-10-20T04:00:00Z,2009,10,2009-10-20T04:00:00Z,,2013-07-27T22:56:12Z,,0,0,0900006480a36819
FDA-2009-N-0374-0004,FDA,FDA-2009-N-0374,"Andrea Leonard-Segal, MD, ""Phase-Out of Chlorofluorocarbon (CFC)-Propelled OTC Epinephrine Metered-Dose Inhalers How to effectively spread the word?"" [Public Workshop, September 25, 2009] - Testimony",Other,TS-Testimony,2009-10-20T04:00:00Z,2009,10,2009-10-20T04:00:00Z,,2013-07-27T22:56:09Z,,0,0,0900006480a35054
FDA-2009-N-0374-0006,FDA,FDA-2009-N-0374,"Leslie Hendeles, Pharm.D., ""Asthma, Epinephrine, and Therapeutic Alternatives"" [Public Workshop, September 25, 2009] - Testimony",Other,TS-Testimony,2009-10-20T04:00:00Z,2009,10,2009-10-20T04:00:00Z,,2013-07-27T22:56:12Z,,0,0,0900006480a36817
FDA-2009-N-0374-0009,FDA,FDA-2009-N-0374,"Ruth Parker, MD, ""Phase Out of CFC-Propelled Epinephrine Inhalation Aerosol: Communication Challenges"" [Public Workshop, September 25, 2009] - Testimony",Other,TS-Testimony,2009-10-20T04:00:00Z,2009,10,2009-10-20T04:00:00Z,,2013-08-11T03:04:30Z,,0,0,0900006480a368ad
FDA-2009-N-0374-0005,FDA,FDA-2009-N-0374,"Badrul A. Chowdhury, MD, PhD, ""Introduction and Background of CFC Propelled Epinephrine Inhalation Aerosol Phase Out"" [Public Workshop, September 25, 2009] - Testimony",Other,TS-Testimony,2009-10-20T04:00:00Z,2009,10,2009-10-20T04:00:00Z,,2013-08-11T03:04:29Z,,0,0,0900006480a35060
FDA-2009-N-0374-0003,FDA,FDA-2009-N-0374,FDA Public Workshop/Faith Dugan - Agenda,Other,MM-Memorandum of Meeting,2009-10-08T04:00:00Z,2009,10,2009-10-08T04:00:00Z,,2013-07-27T22:55:06Z,,0,0,0900006480a291ff
FDA-2009-N-0374-0001,FDA,FDA-2009-N-0374,Educating the Public About Removal of Essential-Use Designation for Epinephrine; Public Workshop; Request for Comments,Notice,NM-Notice of Meeting,2009-08-20T04:00:00Z,2009,8,2009-08-20T04:00:00Z,2009-11-25T04:59:59Z,2009-08-20T15:27:33Z,E9-19985,0,0,0900006480a0e0ba